Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Retained Earnings (2019 - 2023)

Alx Oncology Holdings' Retained Earnings history spans 5 years, with the latest figure at -$226000.0 for Q3 2023.

  • For Q3 2023, Retained Earnings rose 84.97% year-over-year to -$226000.0; the TTM value through Sep 2023 reached -$226000.0, up 84.97%, while the annual FY2022 figure was -$845000.0, 99.58% up from the prior year.
  • Retained Earnings for Q3 2023 was -$226000.0 at Alx Oncology Holdings, up from -$312000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at -$226000.0 in Q3 2023 and bottomed at -$355.7 million in Q1 2023.
  • The 5-year median for Retained Earnings is -$99.7 million (2020), against an average of -$108.3 million.
  • The largest annual shift saw Retained Earnings crashed 73.99% in 2021 before it soared 99.58% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$72.8 million in 2019, then plummeted by 62.85% to -$118.5 million in 2020, then tumbled by 70.42% to -$202.0 million in 2021, then skyrocketed by 99.58% to -$845000.0 in 2022, then soared by 73.25% to -$226000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Retained Earnings are -$226000.0 (Q3 2023), -$312000.0 (Q2 2023), and -$355.7 million (Q1 2023).